Sell Strides Pharma Science, target Rs 386: Kunal Bothra

Independent analyst Kunal Bothra has a sell call on Strides Pharma Science Ltd. with a target price of Rs 386. The current market price of Strides Pharma Science Ltd. is Rs 399.65. Time period given by the analyst is Intra Day when Strides Pharma Science Ltd. price can reach the defined target. Kunal Bothra recommended to keep stoploss at Rs 405. Strides Pharma Science Ltd., incorporated in 1990, has a market cap of Rs 3578.98 crore.

Strides Pharma Science Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 1356.43 Crore to Sales Value (88.22 % of Total Sales), Other Operating Revenue which contributed Rs 97.53 Crore to Sales Value (6.34 % of Total Sales), Export Incentives which contributed Rs 30.40 Crore to Sales Value (1.97 % of Total Sales), Sale of services which contributed Rs 29.58 Crore to Sales Value (1.92 % of Total Sales) and Royalty Income which contributed Rs 23.49 Crore to Sales Value (1.52 % of Total Sales)for the year ending 31-Mar-2019.

For the quarter ended 30-09-2019, the company has reported a Consolidated sales of Rs 715.09 Crore, up 4.27 % from last quarter Sales of Rs 685.80 Crore and down -2.39 % from last year same quarter Sales of Rs 732.63 Crore Company has reported net profit after tax of Rs 163.16 Crore in latest quarter. The company’s top management includes Mr.Arun Kumar, Mr.Badree Komandur, Mr.Bharat D Shah, Mr.Deepak Vaidya, Mr.Homi Rustam Khusrokhan, Mr.S Sridhar, Ms.Sangita Reddy. Company has BSR & Co. LLP as its auditoRs As on 30-09-2019, the company has a total of 89,549,476 shares outstanding.